Hospira Cisplatin 50mg/50ml Concentrate for Infusion vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
29-11-2017

Bahan aktif:

cisplatin, Quantity: 1 mg/mL

Boleh didapati daripada:

Hospira Australia Pty Ltd

INN (Nama Antarabangsa):

Cisplatin

Borang farmaseutikal:

Injection, intravenous infusion

Komposisi:

Excipient Ingredients: mannitol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid

Laluan pentadbiran:

Intravenous Infusion

Unit dalam pakej:

1 X 50mL

Kelas:

Medicine Listed (Export Only)

Jenis preskripsi:

(S1) This Schedule is intentionally blank

Tanda-tanda terapeutik:

Cisplatin is indicated in metastatic, non seminomatous germ cell carcinoma, advanced stage and refractory ovarian carcinoma, advanced stages of refractory bladder carcinoma, advanced stages of refractory bladder carcinoma and squamous cell carcinoma of the head and neck. Cisplatin is indicated in combination with other antineoplastic agents for the treatment of metastatic testicular tumors.

Ringkasan produk:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status kebenaran:

Licence status A

Tarikh kebenaran:

2009-03-10